Dr. Kelly Reveles and Dr. Kirk Evoy.
Two of the College of Pharmacy’s distinguished faculty in the Division of Pharmacotherapy were recommended for promotion by President Hartzell due to their outstanding accomplishments in research, outreach and education. Kelly R. Reveles, Pharm.D., Ph.D., BCPS will assume the rank of associate professor and Kirk Evoy, Pharm.D., BCACP, BC-ADM, CTTS will become a clinical associate professor. Both promotions go into effect September 1, 2022.
Dr. Reveles received her Doctor of Pharmacy degree from UT Austin and UT Health Science Center San Antonio in 2010. She also completed a multi-disciplinary and multi-institutional Translational Science Ph.D. degree from UT Austin, UT Health Science Center San Antonio and UT San Antonio in 2014.
Her long-term research goal is to reduce the incidence and improve the outcomes of healthcare-associated infections by designing, testing and implementing effective clinical strategies. Her current research focus is the prevention and treatment of Clostridioides difficile infections and innovative methods to improve the translation of clinical research findings into practice. Her research approach emphasizes multi-disciplinary, collaborative research in the areas of large database design and analysis, pharmacoepidemiology, comparative-effectiveness research and human and animal microbiome studies.
Dr. Evoy completed his Pre-pharmacy and Doctor of Pharmacy coursework at Purdue University. Upon completion of pharmacy school, he went on to complete a PGY1 Pharmacy Practice Residency at the University of Wisconsin Hospital and Clinics in Madison, Wisconsin followed by a PGY2 Ambulatory Care Residency at Saint Joseph Regional Medical Center in Mishawaka, Indiana. In addition to his residency training, Dr. Evoy completed two teaching certificate programs and a Certificate of Added Training in Global Health and has earned Board Certification as an Ambulatory Care Pharmacist (BCACP), Advanced Diabetes Manager (BC-ADM) and Tobacco Treatment Specialist (CTTS).
His primary areas of research include substance use disorders and smoking cessation. His clinical interests include primary care, particularly diabetes management, smoking cessation, transitions of care and global health.